Pulmonology

Air pollution is driving pediatric risk for lung disease. Are there therapies at hand to address it?

Investigative triple therapy PT010 from AstraZeneca has reached primary outcome results versus a pair of standard dual inhaled therapies.

CDC data show the infectious respiratory disease has been on a decline since at least 2007—though measures are still needed to address its prevalence in certain populations.

A study comparing the LABA agent to maintenance therapy showed results supporting recent GINA recommendations for mild asthma management.

What is the large-scale study looking to bring to clinical respiratory health understanding?

In what ways do the respiratory conditions differentiate in progression and care options?

A 600-city analysis of particulate matter found daily exposure is linked to worsened mortality rates, particularly in areas with higher mean temperatures.

Investigators from the University of Pennsylvania found that negative effects of vaping on blood vessels can be noted after a single use.

Clinicians have indicated which symptom subtypes are associated with a greater risk of cardiovascular conditions in patients with OSA.

In a population-based cohort study, investigators discover how allergy immunotherapy helps allergic rhinitis from progressing to asthma.

The August 14 approval marks the second drug approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs.

The first longitudinal study to assess air pollution and emphysema progression provides novel long-term findings.

How do the states with the longest-running legislation permitting MAID compare?

OSA patients with certain traits experienced a 73% reduction in AHI events from oral appliance treatment.

New phase 3 data will evidence an FDA application for the biologic as an add-on therapy for patients aged 6-11 years with AD.

A new study found significantly greater COPD development risk among middle-aged women who eat processed meat—and doubly worse risk for those who also smoke and have unhealthy diets.

Analysis from the CARDIA Lung study found patients with worsened FEV1 are at greater risk for emphysema, regardless of their smoker status.

Deepak Bhatt, MD, discusses the results of the COMPASS trial and how they have impacted clinical practice.

A new international cohort shows hospitals with a greater annual volume of PE patients often report better patient outcomes.

The prescription device can monitor and share reports on patient's sleep breathing patterns, leading to accurate symptom diagnoses.

New research finds association common sleep disorder present in 14% of suicidal patients with major depressive disorder studied.

A secondary analysis of a 10,000-patient study has linked lower levels of serum albumin to apnea risk in hospitalized infants.

Standardized mortality ratio increased by nearly a full percentage among patients previously treated with TB.

A new assessment of prevalence studies shows some countries could have an OSA prevalence rate of more than half their entire population.

Study of more than 650 COPD patients found that CRP-guided prescribing resulted in a lower percentage of patients who reported antibiotic use.